Press Release
ViVE 2025 AI Power Rankings: Essential Vendors Delivering Tangible Healthcare Outcomes
Black Book Research's rankings are exclusively determined by comprehensive user and client experience surveys. Notably, the organization does not solicit or accept any fees for vendor inclusion or listing, ensuring the integrity and impartiality of its evaluations. Read More
Press Release
Angel Ai CEO Pavan Agarwal and COO Anthony Toro to Sit Ringside for Keyshawn Davis vs. Denys Berinchyk Fight at Madison Square Garden
Angel Ai, the revolutionary financial technology platform breaking barriers in the mortgage industry, will be prominently represented at Madison Square Garden tonight as CEO and Founder Pavan Agarwal and his right-hand man, Anthony Toro, take their seats ringside for the highly anticipated Keyshawn Davis vs. Denys Berinchyk bout, televised live on ESPN. Read More
Press Release
Presidents' Day Rally Against Trump Administration's Practices and His Assault Against the African-American Community
WASHINGTON DC’S NEWLY-APPOINTED AME BISHOP REGINALD T. JACKSON UNITES AFRICAN-AMERICAN FAITH LEADERS FROM ACROSS THE COUNTY, LEADERS FROM THE AMERICAN CIVIL LIBERTIES UNION AND THE NAACP DEFENSE FUND, CONGREGANTS AND FEDERAL EMPLOYEES AT AME METROPOLITAN CHURCH IN WASHINGTON, DC Read More
Press Release
LiCAP Technologies and Windurance Partner With UpTower to Advance Ultracapacitor-Based Retrofit Solution for Wind Energy
LiCAP Technologies Inc. and Windurance, industry-leading providers of ultracapacitor based retrofit solutions for Emergency Pitch Control, are proud to announce a partnership with UpTower, the wind industry's leading provider of installation and technical services. Read More
Press Release
Aptevo Therapeutics Reports 2024 Financial Results And Provides A Business Update
100% of Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable Disease Rate, in ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Makes the Case for Continued Development of First-in-Class Anti-Cancer Agent Read More
Press Release
American Alternative Assets Reviews, Complaints, and Consumer Reports Analysis Released on WireDaily.com
WireDaily has released a new analysis of American Alternative Assets reviews and complaints to help consumers determine if they are reliable and make well-informed decisions. Read More
Press Release
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing Reports full-year revenues of $3.2 billion, GAAP net loss of $(3.6) billion and GAAP diluted EPS of $(9.28) Expects 2025 revenue range of $1.5 to 2.5 billion andending cash balance of approximately $6 billion Submitted three investigational mRNA products for regulatory approval, including Moderna's next-generation COVID vaccine, RSV vaccine for high-risk adults aged 18 to 59, and flu/COVID combination vaccine Read More
Press Release
CFPB Shutdown Leaves Consumers Vulnerable - Legal Action is Now the Best Defense
With the CFPB shut down, banks and lenders now face no federal oversight, putting homeowners and consumers at risk of foreclosure, fraud, and debt collection abuse. Petroff Amshen LLP is stepping in as the last line of defense, taking legal action to hold financial institutions accountable. Without regulatory protection, the only way to fight back is through aggressive litigation. Consumers must act now to protect their rights before it's too late. Read More
Press Release